Global Cell Viability Assays Market is estimated to value over USD 3.9 billion by 2026 end and register CAGR of over 7.1% by 2026 end.
The growing burden of infectious and chronic diseases, increasing focus on cell-based therapeutic development and rising demand for cell-based arrays for research activities are important factors that drive the global cell viability assays market further.
According to the statistics provided by the World Health Organization (WHO), chronic diseases are responsible for around 60% of all deaths across the world and it is predicted by WHO that the occurrence of chronic diseases shall increase by around 57% by 2020. This rising incidences of chronic diseases have increased the demand for efficient healthcare infrastructure. Moreover, according to WHO, nearly 4 out of 5 deaths around the world in 2014, especially in developing countries, occurred due to chronic diseases. According to the Centre for Disease Control and Prevention (CDC), the prevalence of chronic diseases was the main reason for disabilities and deaths in the US in the year 2017. Around 130 million Americans had at least one chronic disease. Additionally, the increase in demand for healthcare spending is due to the rise of lifestyle-related and age-related chronic disease.
Cancer and cardiovascular diseases are the new causes of deaths, especially in the developing economies, as a result of rapid urbanization, changing dietary habits, sedentary lifestyles, widespread availability of tobacco products and rising obesity levels. According to the estimates presented by the CDC, these diseases are the major reason for the death of over 2 million citizens per year in the United States. This growing load of chronic diseases is predicted to propel the global cell viability assays market growth.
Stem Cell Research is Projected to Showcase Remarkable Market Growth Over the Forecast Period
The stem cell research segment is estimated to register a high CAGR value over the forecast period owing to the increase in the research and development activities and funds raised by various organizations for these activities. As per the data from the National Institute of Health (NIH), around USD 2000 million were granted for stem cell research and development activities in the fiscal year 2018. An increase in the number of cell-based treatment centres has assisted in driving stem cell research. Around 580 such centres were established in the US in the year 2015. All these factors are responsible for the proliferation of the global cell viability assays market.

North America is predicted to dominate the market over the forecast period owing to the increase in the prevalence of the chronic disease, high-quality infrastructure and investment initiatives taken by the government. Additional advantages like rising research and development expenditure for the healthcare sector, availability of insurance coverage for lab testing procedures propel the market growth further.
Key market players include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton, Dickinson and Company, Promega Corporation, Biotium, Abcam PLC, Creative Bioarray, Biotek Instruments, Perkinelmer.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3384&page=requestsample
Global Cell Viability Assays Market Segmentation:
By Product
• Consumables
o Reagents
o Assay Kits
§ Tetrazolium Reduction Assay Kits
• Mtt Assay Kits
• Other Tetrazolium Assay Kits
§ Resazurin Cell Viability Assay Kits
§ Calcein-Am Cell Viability Assay Kits
§ Other Assay Kits
o Microplates
• Instruments
o Automated Cell Counters
o Flow Cytometers
o Spectrophometers
o Cell Imaging & Analysis Systems
By Cell Type
• Human Cells
• Animal Cells
• Microbial Cells
By Application
• Drug Discovery and Development
• Basic Research
• Stem Cell Research
• Clinical and Diagnostic Applications
• Other Applications
By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3384&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global cell viability assays market by product, by cell type, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Cell Viability Assays Market Overview
4.2 Cell Viability Assays Market: Geographic Overview (2017)
4.3 Regional Mix: Cell Viability Assays Market (2018–2026)
4.4 Asia Pacific: Cell Viability Assays Market, By End User & Country (2017)
4.5 Cell Viability Assays Market: Developed vs Developing Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence and Prevalence of Chronic and Infectious Diseases
5.2.1.2 Growing Availability of Funds for Research
5.2.1.3 Rising Demand for Cell-Based Assays in Research
5.2.1.4 Increasing Focus on the Development of Cell-Based Therapeutics
5.2.2 Restraint
5.2.2.1 High Cost of Instruments
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Growing Focus on Stem Cell Research

6 Cell Viability Assays Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Reagents
6.2.2 Assay Kits
6.2.2.1 Tetrazolium Reduction Assay Kits
6.2.2.1.1 Mtt Assay Kits
6.2.2.1.2 Other Tetrazolium Assay Kits
6.2.2.2 Resazurin Cell Viability Assay Kits
6.2.2.3 Calcein-Am Cell Viability Assay Kits
6.2.2.4 Other Assay Kits
6.2.3 Microplates
6.3 Instruments
6.3.1 Automated Cell Counters
6.3.2 Flow Cytometers
6.3.3 Spectrophotometers
6.3.4 Cell Imaging & Analysis Systems

7 Cell Viability Assays Market, By Cell Type
7.1 Introduction
7.2 Human Cells
7.3 Animal Cells
7.4 Microbial Cells

8 Cell Viability Assays Market, By Application
8.1 Introduction
8.2 Drug Discovery and Development
8.3 Basic Research
8.4 Stem Cell Research
8.5 Clinical and Diagnostic Applications
8.6 Other Applications

9 Cell Viability Assays Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Research Institutes
9.4 Hospital & Diagnostic Laboratories
9.5 Other End Users

10 Cell Viability Assays Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.6 Middle East & Africa

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.2.1 Market Share Analysis: Cell Viability Assay Kits Market
11.3 Competitive Situation and Trends
11.3.1 Product Launches
11.3.2 Expansions
11.3.3 Acquisitions
11.3.4 Other Strategies

12 Company Profiles
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, FutureWise Perspective)*
12.1 Thermo Fisher Scientific
12.2 Merck KGaA
12.3 Bio-Rad Laboratories
12.4 GE Healthcare
12.5 Danaher Corporation
12.6 Becton, Dickinson and Company
12.7 Promega Corporation
12.8 Biotium
12.9 Abcam PLC
12.10 Creative Bioarray
12.11 Biotek Instruments
12.12 Perkinelmer

13. Research Finding and Conclusion
14. Appendix
15.1 Research Methodology
15 .2 Research Data Source

Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com